deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02411578

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

Mini-Dose Glucagon for Adults With Type 1 Diabetes: A Study to Assess the Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults With Type 1 Diabetes

Sponsor: Jaeb Center for Health Research

Conditions Diabetes Mellitus, Type 1
Interventions G-Pen Mini™ (glucagon injection) Glucose Tablets
Updated 8 times since 2017 Last updated: Feb 28, 2020 Started: Sep 30, 2015 Primary completion: Apr 30, 2016 Completion: May 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Diabetes Mellitus, Type 1, this trial is completed. The trial is conducted by Jaeb Center for Health Research and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshotCompleted~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotCompleted~Jun 2018 – ~Apr 2020 · 22 months · monthly snapshotCompleted~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jun 2018 — Apr 2020 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Nov 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Feb 2017 — Nov 2017 [monthly]

    Completed PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jaeb Center for Health Research
  • Xeris Pharmaceuticals
Data source: Jaeb Center for Health Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations